These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 18477215)

  • 1. New rat model induced by anti-glomerular basement membrane antibody shows severe glomerular adhesion in early stage and quickly progresses to end-stage renal failure.
    Nakano Y; Hirano T; Uehara K; Nishibayashi S; Hattori K; Aihara M; Yamada Y
    Pathol Int; 2008 Jun; 58(6):361-70. PubMed ID: 18477215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
    Liu D; Nazneen A; Taguchi T; Razzaque MS
    Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
    Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N
    J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of podocyte damage in the pathogenesis of glomerulosclerosis and tubulointerstitial lesions: findings in the growth hormone transgenic mouse model of progressive nephropathy].
    Wanke R; Wolf E; Brem G; Hermanns W
    Verh Dtsch Ges Pathol; 2001; 85():250-6. PubMed ID: 11894406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular adventitial cell expression of collagen I messenger ribonucleic acid in anti-glomerular basement membrane antibody-induced crescentic nephritis in the rabbit. A cellular source for interstitial collagen synthesis in inflammatory renal disease.
    Wiggins R; Goyal M; Merritt S; Killen PD
    Lab Invest; 1993 May; 68(5):557-65. PubMed ID: 8497127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotic syndrome induced by dibasic sodium phosphate injections for twenty-eight days in rats.
    Tsuchiya N; Torii M; Narama I; Matsui T
    Toxicol Pathol; 2009 Apr; 37(3):270-9. PubMed ID: 19244217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat.
    Heeringa P; Brouwer E; Klok PA; Huitema MG; van den Born J; Weening JJ; Kallenberg CG
    Am J Pathol; 1996 Nov; 149(5):1695-706. PubMed ID: 8909258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular response to injury in membranous nephropathy.
    Nangaku M; Shankland SJ; Couser WG
    J Am Soc Nephrol; 2005 May; 16(5):1195-204. PubMed ID: 15800119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure.
    Tomita M; Sogabe H; Nakazato S; Nakatsuji S; Noto T; Hamada K; Kawachi H; Shimizu F; Matsuo M; Mutoh S
    Nephrol Dial Transplant; 2005 Nov; 20(11):2358-67. PubMed ID: 16091375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis.
    Remuzzi A; Monaci N; Bonassi ME; Corna D; Zoja C; Mohammed EI; Remuzzi G
    Lab Invest; 1999 Dec; 79(12):1501-10. PubMed ID: 10616201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Masugi nephritis in the rat. An electron microscopic study on evolution and consequences of glomerular capsular adhesions.
    Kondo Y; Akikusa B
    Acta Pathol Jpn; 1982 Mar; 32(2):231-42. PubMed ID: 7090815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.
    Prodromidi EI; Poulsom R; Jeffery R; Roufosse CA; Pollard PJ; Pusey CD; Cook HT
    Stem Cells; 2006 Nov; 24(11):2448-55. PubMed ID: 16873763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody administration in WKY rats.
    Kovalenko P; Fujinaka H; Yoshida Y; Kawamura H; Qu Z; El-Shemi AG; Li H; Matsuki A; Bilim V; Yaoita E; Abo T; Uchiyama M; Yamamoto T
    Int Immunol; 2004 May; 16(5):625-34. PubMed ID: 15096492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
    Vogelbacher R; Wittmann S; Braun A; Daniel C; Hugo C
    Transplantation; 2007 Dec; 84(11):1492-9. PubMed ID: 18091526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune kidney diseases.
    Segelmark M; Hellmark T
    Autoimmun Rev; 2010 Mar; 9(5):A366-71. PubMed ID: 19906361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Approach of cellular mechanisms of glomerulosclerosis in a model of accelerated aging the obese Zucker rat].
    Chevalier J; Masurier C; Lavaud S; Michel O; Bariety J
    C R Seances Soc Biol Fil; 1995; 189(6):987-1007. PubMed ID: 8763029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting podocyte-associated diseases.
    Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.